Physician

David Aaron Burkland, M.D.

According to 2025 Medicare claims, David Burkland, M.D. (NPI: 1609161199) practices cardiac electrophysiology in the Lake Charles, LA market, with the plurality of this provider's patient population coming from Calcasieu, LA. This provider's primary affiliated billing organization is SPECIALTY ASSOCIATES OF WEST HOUSTON PLLC (NPI: 1699062349; TIN: 452298151) and primary practice location at 77004-7005. Burkland is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Burkland's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 522 traditional Medicare patients, billed 2,901 HCPCS/CPT codes, and received $369,131 in Medicare payments. The top billing code was 93656 (Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation). Part D data shows 619 prescription claims across 230 beneficiaries totaling $185,956 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 168 records totaling $24,930. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $87,188 to $369,131. Similarly, Part D prescription costs have risen steadily, from $1,236 to $185,956. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	127	552	$87,188
2020	311	1,577	$260,512
2021	364	2,098	$331,801
2022	397	2,175	$306,646
2023	449	2,688	$343,867
2024	522	2,901	$369,131

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	14	52	$1,236
2016	13	24	$4,345
2017	29	61	$6,944
2018	32	70	$6,931
2019	30	56	$5,096
2020	138	483	$82,323
2021	231	844	$121,522
2022	225	775	$126,896
2023	253	727	$178,330
2024	230	619	$185,956

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93656	Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation	124	129	$732
93655	Insertion of catheters and destruction of tissue to treat abnormal heart rhythm	124	143	$237
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	111	111	$158
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	168	229	$95
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	292	412	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	125	6,816	$130,758
Xarelto	Rivaroxaban	30	2,100	$37,704
Amiodarone Hcl	Amiodarone Hcl	72	3,998	$2,686
Flecainide Acetate	Flecainide Acetate	43	2,850	$1,385
Metoprolol Succinate	Metoprolol Succinate	75	5,670	$1,260

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	168	$24,930	Medical Device Business Services, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Aaron Burkland, M.D.?

Tedicare shows public-source Medicare data for David Aaron Burkland, M.D. (NPI 1609161199), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Aaron Burkland, M.D. have ACO affiliation data?

David Aaron Burkland, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to David Aaron Burkland, M.D.?

David Aaron Burkland, M.D. is linked to SPECIALTY ASSOCIATES OF WEST HOUSTON PLLC (billing NPI 1699062349) in the available physician profile data.

Does David Aaron Burkland, M.D. have Open Payments data?

David Aaron Burkland, M.D. has 168 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.